Financial Analysis: BioLife Solutions (NASDAQ:BLFS) & Glucose Health (OTCMKTS:GLUC)

Glucose Health (OTCMKTS:GLUCGet Free Report) and BioLife Solutions (NASDAQ:BLFSGet Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

Institutional & Insider Ownership

93.2% of BioLife Solutions shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations for Glucose Health and BioLife Solutions, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Glucose Health 0 0 0 0 0.00
BioLife Solutions 1 1 4 0 2.50

BioLife Solutions has a consensus price target of $30.75, suggesting a potential upside of 26.08%. Given BioLife Solutions’ stronger consensus rating and higher probable upside, analysts plainly believe BioLife Solutions is more favorable than Glucose Health.

Profitability

This table compares Glucose Health and BioLife Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Glucose Health N/A N/A N/A
BioLife Solutions -3.20% 0.97% 0.87%

Valuation & Earnings

This table compares Glucose Health and BioLife Solutions”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Glucose Health $380,000.00 6.39 -$320,000.00 ($0.03) -4.34
BioLife Solutions $82.25 million 14.28 -$20.18 million ($0.07) -348.43

Glucose Health has higher earnings, but lower revenue than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Glucose Health, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Glucose Health has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.93, indicating that its share price is 93% more volatile than the S&P 500.

Summary

BioLife Solutions beats Glucose Health on 10 of the 14 factors compared between the two stocks.

About Glucose Health

(Get Free Report)

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.

About BioLife Solutions

(Get Free Report)

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Receive News & Ratings for Glucose Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glucose Health and related companies with MarketBeat.com's FREE daily email newsletter.